Get started
RECCE PHARMACEUTICALSRECCE PHARMACEUTICALSRECCE PHARMACEUTICALS

RECCE PHARMACEUTICALS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Seasonals

RECEF chart


Full chart

RECEF upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪79.30 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0592 USD
Net income (FY)
‪−14.09 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪124.84 M‬
Beta (1Y)
1.31

About Recce Pharmaceuticals Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
James Graham
Website
recce.com.au
Headquarters
Sydney
Founded
2007
ISIN
AU000000RCE5
FIGI
BBG00RHNFY91
Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. It produces antibiotics that are effective in attacking disease-causing Gram-positive and Gram-negative bacteria. The company was founded on April 11, 2007 and is headquartered in Sydney, Australia.

Check out other big names from the same industry as RECEF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RECEF news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RECEF is 0.2200 USD — it has decreased by −56.00% in the past 24 hours. Watch RECCE PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RECCE PHARMACEUTICALS stocks are traded under the ticker RECEF.
We've gathered analysts' opinions on RECCE PHARMACEUTICALS future price: according to them, RECEF price has a max estimate of 1.69 USD and a min estimate of 1.69 USD. Watch RECEF chart and read a more detailed RECCE PHARMACEUTICALS stock forecast: see what analysts think of RECCE PHARMACEUTICALS and suggest that you do with its stocks.
RECEF reached its all-time high on Apr 29, 2025 with the price of 0.6000 USD, and its all-time low was 0.2200 USD and was reached on Jun 24, 2025. View more price dynamics on RECEF chart.
See other stocks reaching their highest and lowest prices.
RECEF stock is 127.27% volatile and has beta coefficient of 1.31. Track RECCE PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is RECCE PHARMACEUTICALS there?
Today RECCE PHARMACEUTICALS has the market capitalization of ‪79.42 M‬, it has decreased by −9.50% over the last week.
Yes, you can track RECCE PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
RECCE PHARMACEUTICALS is going to release the next earnings report on Mar 2, 2026. Keep track of upcoming events with our Earnings Calendar.
RECEF net income for the last half-year is ‪−9.00 M‬ USD, while the previous report showed ‪−4.79 M‬ USD of net income which accounts for −88.16% change. Track more RECCE PHARMACEUTICALS financial stats to get the full picture.
No, RECEF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RECEF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RECCE PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.